New Data Confirm Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Sleep Disturbance For People With Restless Legs Syndrome (RLS)
A new study has shown that pramipexole (Mirapexin®/Sifrol®) can significantly reduce sleep disturbance, often the most troublesome symptom experienced by people with Restless Legs Syndrome (RLS).1 The important finding, presented today at the 60th Annual Meeting of the American Academy of Neurology (AAN) in Chicago, U.S.A.
More: continued here
Filed under: Clinical Trials on April 17th, 2008